• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PNAS: Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin

tetano

Editor, Senior Moderator
Published online before print December 10, 2012, doi: 10.1073/pnas.1218841110
PNAS December 10, 2012 201218841


Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin

Yi Pu Lina,1,
Xiaoli Xionga,b,1,
Stephen A. Whartona,
Stephen R. Martinc,
Peter J. Coombsa,b,2,
Sebastien G. Vachieria,b,
Evangelos Christodouloub,
Philip A. Walkerb,
Junfeng Liua,b,3,
John J. Skehela,
Steven J. Gamblinb,
Alan J. Haya,
Rodney S. Danielsa, and
John W. McCauleya,4

Author Affiliations

Edited by Robert A. Lamb, Northwestern University, Evanston, IL, and approved November 9, 2012 (received for review July 3, 2012)

Abstract

The hemagglutinin (HA) of influenza A(H3N2) virus responsible for the 1968 influenza pandemic derived from an avian virus. On introduction into humans, its receptor binding properties had changed from a preference for avian receptors (α2,3-linked sialic acid) to a preference for human receptors (α2,6-linked sialic acid). By 2001, the avidity of human H3 viruses for avian receptors had declined, and since then the affinity for human receptors has also decreased significantly. These changes in receptor binding, which correlate with increased difficulties in virus propagation in vitro and in antigenic analysis, have been assessed by virus hemagglutination of erythrocytes from different species and quantified by measuring virus binding to receptor analogs using surface biolayer interferometry. Crystal structures of HA?receptor analog complexes formed with HAs from viruses isolated in 2004 and 2005 reveal significant differences in the conformation of the 220-loop of HA1, relative to the 1968 structure, resulting in altered interactions between the HA and the receptor analog that explain the changes in receptor affinity. Site-specific mutagenesis shows the HA1 Asp-225→Asn substitution to be the key determinant of the decreased receptor binding in viruses circulating since 2005. Our results indicate that the evolution of human influenza A(H3N2) viruses since 1968 has produced a virus with a low propensity to bind human receptor analogs, and this loss of avidity correlates with the marked reduction in A(H3N2) virus disease impact in the last 10 y.


http://www.pnas.org/content/early/2012/12/07/1218841110
 
Re: PNAS: Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin

Published Date: 2012-12-12 20:05:49
Subject: PRO/AH/EDR> Influenza (113): A(H3N2) receptor affinity change
Archive Number: 20121212.1448522

INFLUENZA (113): A(H3N2) RECEPTOR AFFINITY CHANGE
*************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org


[1]

Date: Tue 11 Dec 2012

Source: CIDRAP News [edited]

http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/dec1112fluscan.html





A study of the evolution of A(H3N2) influenza viruses since 1968 shows that the current virus has a low propensity to bind to human receptor analog sites, which correlates with the marked reduction in A(H3N2) disease impact in the last 10 years, UK researchers reported yesterday [10 Dec 2012] in the Proceedings of the National Academy of Sciences [abstract reproduced in part 2 below - Mod.CP]. The team used surface biolayer interferometry to measure virus binding to human and avian receptor analogs since the 1968 H3N2 pandemic. They noted that by 2001, the avidity of human H3 viruses for avian receptors had declined 4-fold, and since then, the affinity for human receptors also has decreased significantly. They conclude that this loss of affinity for human receptors "correlates with the marked reduction in A(H3N2) virus disease impact" in the last decade.



--

Communicated by:

ProMED-mail <promed@promedmail.org>




******

[2]

Date: Mon 9 Dec 2012

Source: Proc Natl Acad Sci., early edition [edited]

http://www.pnas.org/content/early/2012/12/07/1218841110.full.pdf


http://www.promedmail.org/direct.php?id=20121212.1448522
 
Re: PNAS: Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin

Proc Natl Acad Sci U S A. 2013 Jan 24. [Epub ahead of print]
Correction for Lin et al., Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.
[No authors listed]

PMID:
23349376
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23349376
 
Back
Top